Free Trial
NASDAQ:ASTH

Astrana Health (ASTH) Stock Price, News & Analysis

Astrana Health logo
$26.54 +5.08 (+23.67%)
As of 10:00 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Astrana Health Stock (NASDAQ:ASTH)

Key Stats

Today's Range
$23.85
$26.51
50-Day Range
$21.46
$26.70
52-Week Range
$21.20
$63.20
Volume
129,010 shs
Average Volume
320,420 shs
Market Capitalization
$1.49 billion
P/E Ratio
36.76
Dividend Yield
N/A
Price Target
$53.29
Consensus Rating
Moderate Buy

Company Overview

Astrana Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
69th Percentile Overall Score

ASTH MarketRank™: 

Astrana Health scored higher than 69% of companies evaluated by MarketBeat, and ranked 304th out of 921 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Astrana Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 6 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Astrana Health has received no research coverage in the past 90 days.

  • Read more about Astrana Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Astrana Health are expected to grow by 22.61% in the coming year, from $1.15 to $1.41 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Astrana Health is 32.97, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 27.84.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Astrana Health is 32.97, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 29.90.

  • Price to Earnings Growth Ratio

    Astrana Health has a PEG Ratio of 0.80. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    Astrana Health has a P/B Ratio of 1.74. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    4.12% of the float of Astrana Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Astrana Health has a short interest ratio ("days to cover") of 5.6.
  • Change versus previous month

    Short interest in Astrana Health has recently increased by 6.99%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Astrana Health does not currently pay a dividend.

  • Dividend Growth

    Astrana Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.12% of the float of Astrana Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Astrana Health has a short interest ratio ("days to cover") of 5.6.
  • Change versus previous month

    Short interest in Astrana Health has recently increased by 6.99%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Astrana Health has a news sentiment score of 0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Astrana Health this week, compared to 5 articles on an average week.
  • Search Interest

    Only 4 people have searched for ASTH on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Astrana Health to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Astrana Health insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    20.00% of the stock of Astrana Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    52.77% of the stock of Astrana Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Astrana Health's insider trading history.
Receive ASTH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Astrana Health and its competitors with MarketBeat's FREE daily newsletter.

ASTH Stock News Headlines

Astrana Health (ASTH) Receives a Buy from TD Cowen
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
See More Headlines

ASTH Stock Analysis - Frequently Asked Questions

Astrana Health's stock was trading at $31.53 at the start of the year. Since then, ASTH shares have decreased by 19.4% and is now trading at $25.4050.

Astrana Health, Inc. (NASDAQ:ASTH) announced its quarterly earnings results on Thursday, August, 7th. The company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.36 by $0.17. The company's revenue for the quarter was up 34.7% compared to the same quarter last year.
Read the conference call transcript
.

Top institutional shareholders of Astrana Health include SteelPeak Wealth LLC (0.96%), Bank of New York Mellon Corp (0.45%), Hussman Strategic Advisors Inc. (0.22%) and Westmount Partners LLC (0.15%).

Shares of ASTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Astrana Health investors own include Tesla (TSLA), JPMorgan Chase & Co. (JPM), NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Netflix (NFLX) and Visa (V).

Company Calendar

Last Earnings
8/07/2025
Today
8/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - OUTP/HM CRE
Sub-Industry
Business Services
Current Symbol
NASDAQ:ASTH
Previous Symbol
NASDAQ:ASTH
CIK
1083446
Employees
1,900
Year Founded
N/A

Price Target and Rating

High Price Target
$70.00
Low Price Target
$36.00
Potential Upside/Downside
+148.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
9 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.72
Trailing P/E Ratio
29.81
Forward P/E Ratio
18.66
P/E Growth
0.8
Net Income
$43.15 million
Net Margins
1.56%
Pretax Margin
2.95%
Return on Equity
4.90%
Return on Assets
2.68%

Debt

Debt-to-Equity Ratio
0.54
Current Ratio
1.70
Quick Ratio
1.70

Sales & Book Value

Annual Sales
$2.03 billion
Price / Sales
0.59
Cash Flow
$1.46 per share
Price / Cash Flow
14.69
Book Value
$14.59 per share
Price / Book
1.47

Miscellaneous

Outstanding Shares
56,060,000
Free Float
44,850,000
Market Cap
$1.20 billion
Optionable
Optionable
Beta
0.85
10 Stocks Set to Soar in Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:ASTH) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners